Roundhill Glp-1 & Weight Loss ETF OZEM

Medalist Rating as of | See Roundhill Investment Hub

Morningstar’s Analysis OZEM

Will OZEM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Roundhill GLP-1 & Weight Loss ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings OZEM

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 66.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.67 7M
Healthcare

Novo Nordisk AS ADR

11.07 6M
Healthcare

Pfizer Inc

7.68 4M
Healthcare

CSPC Pharmaceutical Group Ltd

6.51 4M
Healthcare

Viking Therapeutics Inc

5.46 3M
Healthcare

Kailera Therapeutics Inc

5.16 3M
Healthcare

Chugai Pharmaceutical Co Ltd

4.63 3M
Healthcare

Ascletis Pharma Inc Ordinary Shares

4.38 3M
Healthcare

Amgen Inc

4.36 3M
Healthcare

Hanmi Pharm Co Ltd

4.32 2M
Healthcare

Sponsor Center